The pharma company plans to launch a medicinal chemistry module using students in their third year of their Master of Science study at the University of Nottingham. The project will run over two terms with 12 students and will focus on research, synthesis and testing of PI 3 kinase inhibitors, which are currently under investigation by a number of drug companies. GSK will be researching their potential in the treatment of asthma.
The move comes as large pharmaceutical companies take steps to strengthen partnerships with academia in a bid to boost innovation in research whilst reducing costs.
The scheme will be a great opportunity for students to make a name for themselves as inventors of patents, with the possibility of receiving royalties if their work was translated into a successful drug.
Head of Chemistry at GSK, Dave Allen stated. “This is not a way of saving money, but we are not a charity and we get something back. Our people will mentor, and get a sense of innovation from students.”
Are you looking for a job in Chemistry? Click here to search our current chemistry jobs online now.